-
Mashup Score: 116Hey, Insurance Companies and Pharmacies — Stop Messing Around with the Price of Cheap Generic Drugs - 14 day(s) ago
If you’re practicing medicine these days, you’ve likely experienced some version of this painfully annoying scenario. You prescribe a generic medication, one that’s inexpensive. Your patient goes to the pharmacy, and the pharmacist says that it requires a prior approval. They leave without getting their meds. Here’s a recent example from one of my patients (details […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 114Hey, Insurance Companies and Pharmacies — Stop Messing Around with the Price of Cheap Generic Drugs - 15 day(s) ago
If you’re practicing medicine these days, you’ve likely experienced some version of this painfully annoying scenario. You prescribe a generic medication, one that’s inexpensive. Your patient goes to the pharmacy, and the pharmacist says that it requires a prior approval. They leave without getting their meds. Here’s a recent example from one of my patients (details […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 164The Rise and Fall of Paxlovid - 22 day(s) ago
It’s been quite the ride for our “preferred” outpatient therapy for COVID-19, nirmatrelvir with ritonavir — much better known as Paxlovid, so allow me the license to use the licensed name. Let’s recap the astonishing success and now failure of this intervention: December 2021, the FDA issued an Emergency Use Authorization for Paxlovid: Action is based on […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 14How to Induce Rage in a Doctor - 23 day(s) ago
If you’re wondering how to make a doctor angry — really, really angry — read on. Because asking us to justify treatment decisions to insurance companies and their pharmacy benefit managers must rank right up there with the greatest tortures of practicing medicine in this country. Mind you, this isn’t just about my patient, or about […]
Source: blogs.jwatch.orgCategories: General Medicine News, HIV/AIDSTweet
-
Mashup Score: 160The Rise and Fall of Paxlovid - 1 month(s) ago
It’s been quite the ride for our “preferred” outpatient therapy for COVID-19, nirmatrelvir with ritonavir — much better known as Paxlovid, so allow me the license to use the licensed name. Let’s recap the astonishing success and now failure of this intervention: December 2021, the FDA issued an Emergency Use Authorization for Paxlovid: Action is based on […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 154The Rise and Fall of Paxlovid - 1 month(s) ago
It’s been quite the ride for our “preferred” outpatient therapy for COVID-19, nirmatrelvir with ritonavir — much better known as Paxlovid, so allow me the license to use the licensed name. Let’s recap the astonishing success and now failure of this intervention: December 2021, the FDA issued an Emergency Use Authorization for Paxlovid: Action is based on […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 144The Rise and Fall of Paxlovid - 1 month(s) ago
It’s been quite the ride for our “preferred” outpatient therapy for COVID-19, nirmatrelvir with ritonavir — much better known as Paxlovid, so allow me the license to use the licensed name. Let’s recap the astonishing success and now failure of this intervention: December 2021, the FDA issued an Emergency Use Authorization for Paxlovid: Action is based on […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 183
I took care of a patient many years ago with MRSA. The severity of the infection required a prolonged treatment course, and vancomycin was the default option. Cripes, it was the only option. He ultimately was discharged on home IV therapy, and as usual we had a plan to monitor his renal function and vancomycin […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 165
I took care of a patient many years ago with MRSA. The severity of the infection required a prolonged treatment course, and vancomycin was the default option. Cripes, it was the only option. He ultimately was discharged on home IV therapy, and as usual we had a plan to monitor his renal function and vancomycin […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 163
I took care of a patient many years ago with MRSA. The severity of the infection required a prolonged treatment course, and vancomycin was the default option. Cripes, it was the only option. He ultimately was discharged on home IV therapy, and as usual we had a plan to monitor his renal function and vancomycin […]
Source: blogs.jwatch.orgCategories: General Medicine News, General HCPsTweet
Hey insurance companies and pharmacy benefit managers and pharmacies -- requiring a prior approval and inflating the charge for a cheap generic drug makes zero sense! It's bad for patients and is unethical. Stop it already! Exhibit #1: Linezolid. https://t.co/AwCIeo1QMX